Emerging CAR-T Therapies in Large B-cell Lymphomas (LBCL): Highlights from ASH 2022 and Beyond - Episode 8

Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL

,

Closing out this discussion of post-ASH 2022 perspectives, Matthew Lunning, DO, FACP, shares important clinical practice pearls for physicians considering CAR T-cell therapy for patients with LBCL.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Overview of Large B-Cell Lymphoma (LBCL)
    EP. 2: Treatment Strategies for Patients with R/R LBCL
    EP. 3: CAR T-Cell Therapy in R/R LBCL: TRANSFORM, ZUMA-7, and PILOT Studies
    EP. 4: CAR T-Cell Therapy as Second-Line Treatment in LBCL
    EP. 5: Choosing the Appropriate CAR T-Cell Therapy in Patients with R/R DLBCL
    EP. 6: Additional Key Data Updates from ASH 2022 on Treatment of LBCL
    EP. 7: Treatment Sequencing in LBCL: Clinical Trial and Real-World Data
    Now Viewing
    EP. 8: Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL

    x